骨保护素配体,osteoprotegerin ligand英语短句,例句大全

骨保护素配体,osteoprotegerin ligand
1)osteoprotegerin ligand骨保护素配体
1.The rumor-necrosis-factor-family molecule osteoprotegerin ligand(OPGL; also known as TRANCE,RANKL and ODF)has been lately identified as a potential osteoclast differentiation factor that distributes in bone,blood and immune system.肿瘤坏死因子家族成员骨保护素配体(osteoprotegerin ligand，OPGL；又称TRANCE，RANKL，ODF)是近年发现的在动物的骨、血液及免疫系统等处分布的，促进破骨细胞分化的蛋白分子。

英文短句/例句

1.A Study on Osteoprotegerin Ligand and Receptor Activator of Nuclear Factor κ-B Express during the Replacement of Dogs Primary and Permanent Teeth;犬乳恒牙替换期骨保护素配体和核因子κB受体活化剂表达的研究
2.OSTEOPROTEGRIN AND RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B LIGAND mRNAs EXPRESSION IN BMSCs OF GLUCOCORTICOID-INDUCED NECROSIS OF THE FEMORAL HEAD PATIENTS激素性股骨头坏死BMSCs骨保护素/NF-κB受体活化因子配基mRNA的表达
3.Effects of Resveratrol on Osteoprotegerin and Osteoprotegerin Ligand Expression of Femurs in Ovariectomized Rats;白藜芦醇对去卵巢大鼠股骨骨保护素及其配体表达的影响
4.Age Effect on OPG and OPGL Expression in Periodontal Ligament Cells during Orthodontic Tooth Movement;增龄因素对鼠正畸牙牙周组织骨保护素及其配体表达的影响
5.Influnce of OPG and RANKL on duck′s osteoclasts formation and activation in vitro骨保护素和核因子κB受体活化因子配基对体外培养鸭破骨细胞的影响
6.Changes of receptor activator of nuclear factor kappa B ligand and osteoprotegerin expression in ovariectomized rats去卵巢后大鼠骨组织中核因子κB受体活化因子配体和骨保护素表达的变化
7.Effects of cobalt and chromium ions on osteoblasts:cytotoxicity and the releasion of RANKL and OPG钴铬离子对成骨细胞细胞毒性及对其分泌骨保护素及其配体的影响
8.Regulation of adult rat condyle receptor activator of nuclear factor kappa B ligand/osteoprotegerin by intermaxillary traction force颌间牵引力对成年大鼠髁状突核因子κB受体活化因子配基/骨保护素的调控
9.Construction and Primary Expression of Human Osteoprotegerin in Mammalian Vectors;人骨保护素哺乳类表达载体的构建及初步表达
10.Effect of adiponectin on the expression of osteoprotegerin and receptor activator of nuclear factor-kappa B ligand in osteoblasts脂联素对成骨细胞护骨素和核转录因子κB受体活化素配体表达的影响
11.Regulation of receptor activator of nuclear factor-κB ligand-receptor activator of nuclear factor-κB and osteoprotegerin in bone modeling and remodeling核转录因子-κB受体活化因子及其配体和骨保护蛋白系统在骨构建与骨改建中的作用
12.Expression of soluble receptor activator of nuclear factor-κB ligand and osteoprotegerin of the os-teoblast in adolescent idiopathic scoliosis patients青少年特发性脊柱侧凸患者成骨细胞中核因子κB受体活化子配体和骨保护蛋白的表达
13.Study on Relationship between Bone Osteoprotegerin Ligand and Bone Changes in Chronic Fluorosis Rats under Two Calcium Nutritional Conditions;不同钙营养状态下骨保护蛋白配体与慢性氟中毒大鼠骨质改变关系的研究
14.Construction, Optimization and Expression of Mammalia Recombinant Vector for Truncated Fragment of Human Osteoprotegerin截短型人骨保护素哺乳类载体的构建、优化及表达
15.Effect of recombinant osteoprotegerin on glucocorticoid-induced osteoporosis in rats重组骨保护蛋白对糖皮质激素性骨质疏松的保护作用
16.A Study on the Expression of Osteoprotegerin during the Replacement of Dog s Primary and Permanent Teeth;犬乳恒牙替换期骨保护素表达的研究
17.Experimental Study of the Osteoprotegerin and the Ovariectomized Rat Model of Osteoporosis;骨保护素与去卵巢大鼠骨质疏松模型实验研究
18.Relationship between Serum Osteoprotegerin Level and Osteoporosis of Type 2 Ddiabetes Patients2型糖尿病患者骨保护素与骨质疏松的关系

相关短句/例句

OPGL骨保护素配体
1.Specific inhibition of OPGL expression by RNA interference;RNAi法特异性抑制骨保护素配体
2.Osteoprotegerin(OPG) is a physiological cytokine inhibiting bone resorption resulting from osteoclast,while Osteoprotegerin ligand(OPGL) is a cytokine which can directly induce osteoclast differentiation and development as well as mediate function regulation of osteoclast.骨保护素(OPG)是生理性的抑制破骨细胞性骨吸收的因子,而骨保护素配体(OPGL)是能直接诱导破骨细胞分化发育并参与破骨细胞功能调节的细胞因子。
3)Osteoprotegerin ligand骨保护素配体(OPGL)
4)receptor activator of nuclear factor kappa B ligand护骨素配体
1.Objective To investigate the effect of kdney-tonifying tranditional Chinese medicine,Gu Ling Pian(GLP)on regulating human osteoblasts function and the osteoprotegerin(OPG)/receptor activator of nuclear factor kappa B ligand(RANKL)expression via p38 MAPK pathway in vitro.采用Western-blot及Real time RT-PCR的方法观察各组成骨细胞护骨素和护骨素配体基因表达和磷酸化p38含量,用MTT法测定各组成骨细胞增殖率,利用茜素红染色法测定矿化结节形成的数量。
5)RANKL护骨素配体
1.The expression of the OPG, RANKL and M-CSF mRNA, cell proliferation and formation of mineralized bone nodule, the total protein of p38 and phosphorylated p38, were observed or quantitatively me.采用Western-blotting及RealtimeRT-PCR方法观察各组成骨细胞护骨素(OPG)、护骨素配体(RANKL)以及巨噬细胞集落刺激因子(M-CSF)基因表达和磷酸化p38含量。
6)Osteoprotegerin/the ligand of osteoprotegerin(OPG/OPGL)护骨素护骨素配体(OPG/OPGL)